Treatment Rationale and Design for J-AXEL: A Randomized Phase 3 Study Comparing Nab-Paclitaxel With Docetaxel in Patients With Previously Treated Advanced Non–Small-Cell Lung Cancer

2017 ◽  
Vol 18 (1) ◽  
pp. 100-103 ◽  
Author(s):  
Yasuto Yoneshima ◽  
Satoshi Morita ◽  
Masahiko Ando ◽  
Satoru Miura ◽  
Hiroshige Yoshioka ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Small Cell Lung Cancer ◽  
Cell Lung Cancer ◽  
Small Cell ◽  
Small Cell Lung ◽  
Phase 3 ◽  
Previously Treated

scholarly journals Phase 3 trial comparing nab-paclitaxel with docetaxel for previously treated advanced non–small cell lung cancer

2021 ◽  
Author(s):  
Yasuto Yoneshima ◽  
Satoshi Morita ◽  
Masahiko Ando ◽  
Atsushi Nakamura ◽  
Shunichiro Iwasawa ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Small Cell Lung Cancer ◽  
Cell Lung Cancer ◽  
Small Cell ◽  
Small Cell Lung ◽  
Phase 3 ◽  
Previously Treated

scholarly journals Atezolizumab in Japanese Patients With Previously Treated Advanced Non–Small-Cell Lung Cancer: A Subgroup Analysis of the Phase 3 OAK Study

2018 ◽  
Vol 19 (4) ◽  
pp. e405-e415 ◽  
Author(s):  
Toyoaki Hida ◽  
Reiko Kaji ◽  
Miyako Satouchi ◽  
Norihiko Ikeda ◽  
Atsushi Horiike ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Small Cell Lung Cancer ◽  
Cell Lung Cancer ◽  
Subgroup Analysis ◽  
Japanese Patients ◽  
Small Cell ◽  
Small Cell Lung ◽  
Phase 3 ◽  
Previously Treated

scholarly journals ALUR: a phase 3 study of alectinib versus chemotherapy in previously treated ALK+ non-small cell lung cancer (NSCLC)

2016 ◽  
Vol 27 ◽  
pp. vi449 ◽  
Author(s):  
J. Wolf ◽  
I.-J. Oh ◽  
J. Mazieres ◽  
J. de Castro ◽  
C. Revil ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Small Cell Lung Cancer ◽  
Cell Lung Cancer ◽  
Small Cell ◽  
Small Cell Lung ◽  
Phase 3 ◽  
Previously Treated
Sign in / Sign up

Export Citation Format

Share Document